Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma

JAMA

Volumn 295, Issue 10, 2006, Pages 1142-1146

  Chidambaram, Jaya D ^a   Alemayehu, Wondu ^c   Melese, Muluken ^c   Lakew, Takele ^c   Yi, Elizabeth ^a   House, Jenafir ^a   Cevallos, Vicky ^a   Zhou, Zhaoxia ^a   Maxey, Kathryn ^a   Lee, David C ^a   Shapiro, Brett L ^a   Srinivasan, Muthiah ^d   Porco, Travis ^a,e   Whitcher, John P ^a,b   Gaynor, Bruce D ^a,b   Lietman, Thomas M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ORBIS INTERNATIONAL   (Ethiopia)

^d ARAVIND EYE HOSPITAL   (India)

^e CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; CHLAMYDIASIS; COHORT ANALYSIS; COMMUNITY; CONFIDENCE INTERVAL; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; TIME SERIES ANALYSIS; TRACHOMA;

EID: 33644799318     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.295.10.1142     Document Type: Article

References (24)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82:844-851.
2. Mariotti SP. New steps toward eliminating blinding trachoma. N Engl J Med. 2004;351:2004-2007.
3. Report of the Eighth Meeting of the WHO Alliance for the Global Elimination of Blinding Trachoma. Geneva, Switzerland: World Health Organization; 2004. WHO/PBD/GET/04.2.
4. Schachter J, West SK, Mabey D, et al. Azithromycin in control of trachoma. Lancet. 1999;354:630-635.
5. Melese M, Chidambaram JD, Alemayehu W, et al. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA. 2004;292:721-725.
6. Solomon AW, Holland MJ, Alexander ND, et al. Mass treatment with single-dose azithromycin for trachoma. N Engl J Med. 2004;351:1962-1971.
7. Gaynor BD, Miao Y, Cevallos V, et al. Eliminating trachoma in areas with limited disease. Emerg Infect Dis. 2003;9:596-598.
8. Lietman T, Porco T, Dawson C, Blower S. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nat Med. 1999;5:572-576.
9. Gaynor BD, Yi E, Lietman T. Rationale for mass antibiotic distribution for trachoma elimination. Int Ophthalmol Clin. 2002;42:85-92.
10. Zhang J, Lietman T, Olinger L, Miao Y, Stephens RS. Genetic diversity of Chlamydia trachomatis and the prevalence of trachoma. Pediatr Infect Dis J. 2004;23:217-220.
11. Chidambaram JD, Lee DC, Porco TC, Lietman TM. Mass antibiotics for trachoma and the Allee effect. Lancet Infect Dis. 2005;5:194-196.
12. Solomon AW, Foster A, Mabey DC. Single dose azithromycin for trachoma [letter]. N Engl J Med. 2005;352:414-415.
13. Verrengia JB. Antibiotic dose may help stop world's leading cause of preventable blindness [press release]. New York, NY: Associated Press; November 3, 2004.
14. Bird M, Dawson CR, Schachter JS, et al. Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas? J Infect Dis. 2003;187:1669-1673.
15. Diamant J, Moncada J, Pang F, et al. Pooling of chlamydial laboratory tests to determine prevalence of trachoma. Ophthalmic Epidemiol. 2001;8:109-117.
16. Peeling RW, Toye B, Jessamine P, Gemmill I. Pooling of urine specimens for PCR testing: a cost saving strategy for Chlamydia trachomatis control programmes. Sex Transm Infect. 1998;74:66-70.
17. Lietman TM, Gaynor B, Porco T. Single-dose azithromycin for trachoma [letter]. N Engl J Med. 2005;352:414-415.
18. West ES, Munoz B, Mkocha H, et al. Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community. Invest Ophthalmol Vis Sci. 2005;46:83-87.
19. Burton MJ, Holland MJ, Makalo P, et al. Reemergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet. 2005;365:1321-1328.
20. Wang SA, Papp JR, Stamm WE, Peeling RW, Martin DH, Holmes KK. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. J Infect Dis. 2005;191:917-923.
21. Jha H, Chaudary J, Bhatta R, et al. Disappearance of trachoma in western Nepal. Clin Infect Dis. 2002;35:765-768.
22. Dolin PJ, Faal H, Johnson GJ, et al. Reduction of trachoma in a sub-Saharan village in absence of a disease control programme. Lancet. 1997;349:1511-1512.
23. Chidambaram JD, Bird M, Schiedler V, et al. Trachoma decline and widespread use of antimicrobial drugs. Emerg Infect Dis. 2004;10:1895-1899.
24. Hoechsmann A, Metcalfe N, Kanjaloti S, et al. Reduction of trachoma in the absence of antibiotic treatment: evidence from a population-based survey in Malawi. Ophthalmic Epidemiol. 2001;8:145-153.